Zhigang Luo

551 total citations
23 papers, 427 citations indexed

About

Zhigang Luo is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Zhigang Luo has authored 23 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Zhigang Luo's work include RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers) and Circular RNAs in diseases (3 papers). Zhigang Luo is often cited by papers focused on RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers) and Circular RNAs in diseases (3 papers). Zhigang Luo collaborates with scholars based in China and United States. Zhigang Luo's co-authors include Yilan Zhen, Liuyi Dong, Sheng Li, Yanan Wang, Ning Yang, Zhi Zhu, Zhihao Zhu, Dachun Yang, Ming-hua Zhu and Fugang Li and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and American Journal Of Pathology.

In The Last Decade

Zhigang Luo

22 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhigang Luo China 12 224 95 60 52 51 23 427
Huimin Bian China 11 234 1.0× 79 0.8× 49 0.8× 24 0.5× 34 0.7× 19 564
Eskandar Qaed China 12 236 1.1× 78 0.8× 59 1.0× 41 0.8× 44 0.9× 30 442
Hongjiao Xiang China 13 285 1.3× 97 1.0× 64 1.1× 35 0.7× 45 0.9× 21 537
Ke‐Xue Li China 12 207 0.9× 73 0.8× 34 0.6× 32 0.6× 63 1.2× 17 465
Lan Miao China 15 269 1.2× 54 0.6× 113 1.9× 46 0.9× 52 1.0× 41 481
Hanying Xing China 13 204 0.9× 155 1.6× 49 0.8× 21 0.4× 45 0.9× 19 406
Honit Piplani United States 16 276 1.2× 69 0.7× 74 1.2× 57 1.1× 45 0.9× 25 580

Countries citing papers authored by Zhigang Luo

Since Specialization
Citations

This map shows the geographic impact of Zhigang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigang Luo more than expected).

Fields of papers citing papers by Zhigang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhigang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigang Luo. The network helps show where Zhigang Luo may publish in the future.

Co-authorship network of co-authors of Zhigang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhigang Luo. A scholar is included among the top collaborators of Zhigang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhigang Luo. Zhigang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yong, Shan Liu, Ning Yang, et al.. (2023). circ_0001274 Competitively Binds miR-143-3p to Upregulate VWF Expression to Improve Acute Traumatic Coagulopathy. Oxidative Medicine and Cellular Longevity. 2023. 1–18. 2 indexed citations
2.
Liu, Yiqi, et al.. (2023). Non-coding RNAs in renal cell carcinoma: Implications for drug resistance. Biomedicine & Pharmacotherapy. 164. 115001–115001. 9 indexed citations
3.
Peng, Xiaoqing, et al.. (2022). Current Studies of Mitochondrial Quality Control in the Preeclampsia. Frontiers in Cardiovascular Medicine. 9. 836111–836111. 8 indexed citations
4.
Luo, Yong, Yiqi Liu, Xin Li, et al.. (2022). The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies. BMC Medicine. 20(1). 39–39. 19 indexed citations
5.
Luo, Zhigang, et al.. (2021). E3 ubiquitin ligase PJA1 regulates lung adenocarcinoma apoptosis and invasion through promoting FOXR2 degradation. Biochemical and Biophysical Research Communications. 556. 106–113. 9 indexed citations
6.
Xie, Juan‐Juan, Xin Li, Yufang Lü, et al.. (2021). Female chronic posterior urethritis is underestimated in patients with lower urinary tract symptoms. Translational Andrology and Urology. 10(8). 3456–3464. 2 indexed citations
7.
Xie, Juan‐Juan, et al.. (2020). “Sandwich” mesh reconstruction of female giant urethral diverticulum: a case report. BMC Urology. 20(1). 32–32.
8.
Liang, Xiaoshan, et al.. (2020). [Electrolytic drinking water improves the metabolism of uric acid in the SD rats with hyperuricemia].. PubMed. 49(5). 802–808. 1 indexed citations
9.
Luo, Zhigang, et al.. (2020). RNF115-mediated ubiquitination of p53 regulates lung adenocarcinoma proliferation. Biochemical and Biophysical Research Communications. 530(2). 425–431. 18 indexed citations
10.
Li, Fugang, Li Liu, Xiaolan Guo, et al.. (2019). Elevated cytokine levels associated with acute kidney injury due to wasp sting. European Cytokine Network. 30(1). 34–38. 17 indexed citations
11.
Luo, Zhigang, et al.. (2019). LINC00958 Accelerates Cell Proliferation and Migration in Non-Small Cell Lung Cancer Through JNK/c-JUN Signaling. Human Gene Therapy Methods. 30(6). 226–234. 22 indexed citations
12.
Yang, Ning, Ling Wang, Jun Liu, et al.. (2018). MicroRNA‑206 regulates the epithelial‑mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2. Oncology Letters. 15(6). 8295–8302. 14 indexed citations
13.
14.
Chen, Xian, Yi Wang, Hongmei Luo, et al.. (2014). Hydrogen sulfide reduces kidney injury due to urinary-derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels. Experimental and Therapeutic Medicine. 8(2). 464–470. 29 indexed citations
15.
Cheng, Long, Feng Tian, Feng Tian, et al.. (2013). Repression of Farnesoid X Receptor Contributes to Biliary Injuries of Liver Grafts Through Disturbing Cholangiocyte Bile Acid Transport. American Journal of Transplantation. 13(12). 3094–3102. 11 indexed citations
16.
Chen, Xian, Yi Wang, Hongmei Luo, et al.. (2013). Ulinastatin reduces urinary sepsis-related inflammation by upregulating IL-10 and downregulating TNF-α levels. Molecular Medicine Reports. 8(1). 29–34. 20 indexed citations
17.
Dong, Liuyi, et al.. (2013). Cardioprotection of Vitexin on Myocardial Ischemia/Reperfusion Injury in Rat via Regulating Inflammatory Cytokines and MAPK Pathway. The American Journal of Chinese Medicine. 41(6). 1251–1266. 75 indexed citations
18.
Ma, Shitang, et al.. (2010). Uncoupling Protein 2 Ablation Exacerbates High-Salt Intake-Induced Vascular Dysfunction. American Journal of Hypertension. 23(8). 822–828. 40 indexed citations
19.
Tong, Xin, Kai Li, Zhigang Luo, et al.. (2009). Decreased TIP30 Expression Promotes Tumor Metastasis in Lung Cancer. American Journal Of Pathology. 174(5). 1931–1939. 58 indexed citations
20.
Zhu, Zhi, Zhigang Luo, Yongmei Li, et al.. (2008). Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner #. Hepatology. 49(2). 504–512. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huimin Bian Breakdown of academic impact, for papers by Eskandar Qaed Breakdown of academic impact, for papers by Hongjiao Xiang Breakdown of academic impact, for papers by Ke‐Xue Li Breakdown of academic impact, for papers by Lan Miao Breakdown of academic impact, for papers by Hanying Xing Breakdown of academic impact, for papers by Honit Piplani
Rankless by CCL
2026